Tetra Bio-Pharma Discusses Their 2020 Growth Strategy with The Stock Day Podcast
Jan 21, 2020, 01:16 PM
The Stock Day Podcast welcomed Tetra Bio-Pharma (TSX-V:TBP)(TBPMF), a biopharmaceutical leader in cannabinoid- based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Chief Scientist and Founder of the Company, Dr. Guy Chamberland, joined Stock Day host Everett Jolly.